HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sayantani B Sindher Selected Research

Sayantani B Sindher Research Topics

Disease

15Hypersensitivity (Allergy)
03/2024 - 07/2018
13Food Hypersensitivity (Food Allergy)
03/2024 - 10/2018
10Peanut Hypersensitivity (Peanut Allergy)
03/2024 - 09/2018
4COVID-19
11/2023 - 01/2022
2Eosinophilic Esophagitis
01/2023 - 01/2021
2Anaphylaxis (Anaphylactic Shock)
01/2022 - 01/2021
2Asthma (Bronchial Asthma)
01/2022 - 07/2018
2Atopic Dermatitis (Atopic Eczema)
01/2022 - 01/2020
1Milk Hypersensitivity (Milk Allergy)
02/2024
1Injection Site Reaction
01/2024
1Lung Diseases (Lung Disease)
01/2022
1Infections
01/2022
1Inflammation (Inflammations)
01/2020
1Opportunistic Infections (Opportunistic Infection)
02/2015
1Immune Reconstitution Inflammatory Syndrome
02/2015
1Chronic Urticaria
11/2012

Drug/Important Bio-Agent (IBA)

8AllergensIBA
02/2024 - 01/2020
6Immunoglobulin E (IgE)IBA
02/2024 - 07/2018
4AntigensIBA
11/2023 - 01/2022
4Biomarkers (Surrogate Marker)IBA
11/2023 - 10/2018
4VaccinesIBA
11/2023 - 01/2021
3Omalizumab (Xolair)FDA Link
01/2024 - 07/2018
3mRNA VaccinesIBA
01/2023 - 01/2021
2dupilumabIBA
03/2024 - 01/2023
2AntibodiesIBA
03/2024 - 01/2022
2Proteins (Proteins, Gene)FDA Link
05/2023 - 01/2022
2COVID-19 VaccinesIBA
01/2023 - 01/2021
2EmollientsIBA
10/2022 - 01/2020
2Epinephrine (Adrenaline)FDA LinkGeneric
01/2022 - 01/2020
2Immunoglobulin G (IgG)IBA
01/2022 - 01/2021
2Messenger RNA (mRNA)IBA
01/2022 - 01/2021
1tezepelumabIBA
03/2024
1ligelizumabIBA
03/2024
1anti-IgE antibodiesIBA
01/2024
1AvidinIBA
11/2023
1Excipients (Suspending Agents)IBA
01/2023
1Vaccine ExcipientsIBA
01/2023
1SteroidsIBA
10/2022
1BIBP COVID-19 vaccineIBA
01/2022
1remdesivirIBA
01/2022
1BNT162 VaccineIBA
01/2022
1LeguminsIBA
01/2021
1Histamine Antagonists (Antihistamines)IBA
01/2020
1DNA (Deoxyribonucleic Acid)IBA
10/2018
1Vitamin DFDA LinkGeneric
11/2012

Therapy/Procedure

14Immunotherapy
03/2024 - 09/2018
3Therapeutics
01/2022 - 07/2018
2Biological Therapy
11/2023 - 02/2015
1Secondary Prevention
01/2020
1Highly Active Antiretroviral Therapy (HAART)
02/2015